期刊文献+

帕金森病的干细胞移植及其基因治疗研究进展 被引量:1

下载PDF
导出
摘要 随着神经干细胞研究的发展以及分子生物学技术的进步 ,神经干细胞移植及基因治疗已成为帕金森病治疗的主要研究方向。本文回顾了帕金森病的治疗现状、移植神经干细胞的来源、相关的修复机制及神经干细胞联合基因治疗帕金森病的进展作一综述。
出处 《神经疾病与精神卫生》 2004年第1期59-61,共3页 Journal of Neuroscience and Mental Health
基金 上海市科学技术发展基金重点资助项目 (0 2 4 1 1 90 37)
  • 相关文献

参考文献25

  • 1[1]Beal MF.Experimental models of Parkinson's disease[J].Nature Rev Neurosci,2001,2:325-334.
  • 2[2]Siderowf A,Stern M.Update on Parkinson Disease[J].Ann Intern Med,2003,138(8):651-658.
  • 3[3]Bjorklund A,Lindvall O.Parkinson disease gene therapy moves toward the clinic[J].Nature Med,2000,6:1207-1208.
  • 4[4]Bronte-Stewart H.Parkinson's Disease:Surgical Options[J].Curr Treat Options Neurol,2003,5(2):131-147.
  • 5[5]Freed CR,Greene PE,Breeze RE,et al.Transplantation of embryonic dopamine neurons for severe Parkinson's disease [J].NEnglJ Med,2001,344:710-719.
  • 6[6]Barinaga M.Fetal neuron grafts pave the way for stem cell therapies[J].Science,2000,287(5457):1421-1422.
  • 7[7]Fricker RA,Carpenter MK,Winkler C,et al.Site-specific migration and neuronal differentiation of human neural progenitor cells after transplantation in the adult rat brain[J].J Neurosci,1999,19:5990-6005.
  • 8[8]Storch A,Paul G,Csete M,et al.Long-term proliferation and dopaminergic differentiation of human mesencephalic neural precursor cells[J].Exp Neurol,2001,170(2):317-325.
  • 9[9]Wagner J,Akerud P,Castro DS,et al.Induction of a midbrain dopaminergic phenotype in Nurrl-overexpressing neural stem cells by type 1 astrocytes[J].Nat Biotechnol,1999,17(7):653-659.
  • 10[10]Storch A,Schwarz J.Neural stem cells and Parkinson's disease[J].J Neurol,2002,249(Sup):30-32.

同被引文献16

  • 1江澄川,夏鹰,汪洋,丁忠良,徐斌,冯林音.雪旺细胞和神经干细胞共移植治疗大鼠帕金森病的实验研究[J].中华神经医学杂志,2006,5(8):785-788. 被引量:4
  • 2王晶,李亚里,彭红梅.细胞移植治疗帕金森病的研究进展[J].中国组织工程研究与临床康复,2007,11(12):2291-2294. 被引量:4
  • 3Siderowf A, Stern M, Update on Parkinson disease [J]. Ann Intern Med,2003,138(8):651-658.
  • 4Lindvall O. Neural transplantation in Parkinson' s disease[J ]. Novartis Found Syrnp 2000,231 : 110 - 123.
  • 5Shamash S, Reichert F, Rotshenker S. The cytokine network of Wallerian degeneration: tumor necrosis factor - alpha, interleukin - lalpha and interleukin beta[J]. J Neurosci 2002;22(8) :3052 - 3060.
  • 6Storch A, Sabolek M, Milosevic J, et al. Midbrain derived neural stem cells: from basic science to therapeutic approaches [ J ]. Cell Tissue Res2004 ; 318 ( 1 ) : 15 - 22.
  • 7Fricker RA, Carpenter MK, Winkler C, et al. Site - specific migration and neuronal differentiation of human neural progenitor cells after transplantation in the adult rat brain[J]. J Neurosci, 1999, 19:5 990 - 6 005.
  • 8Wagner J, Akerud P, Castro DS, dopaminergic phenotype in Nurrl et al. Induction of a midbrain - overexpressing neural stem cells by type 1 astrocytes[J]. Nat Biotechnol, 1999,17(7) :653 659.
  • 9Storch A, Schwarz J. Neural stem cells and Parkinson' s disease [J]. J Neurol, 2002,249 (Sup):30-32.
  • 10bryonic stem cells for the treatment of mouse parkinsonian models : improved behavior by transplantation of in vitro differentiated doparninergic neurons from embryonic stem cells[J]. Stem Cells, 2003,21(2): 171- 180.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部